AN IMPLANTABLE EXTERNAL VASCULAR DEVICE, DESIGNED TO BE PLACED AROUND VASCULAR JOINT AND PROMOTE HEALTHY, CONTROLLED HEALING FOLLOWING ARTERIAL OR VENOUS BYPASS SURGERY
FloGuardian™ addresses the principal cause of vascular graft failure following vascular access, arterial and venous bypass surgery.
There are around 2 million procedures carried out each year requiring such grafts
The healthcare costs associated with haemodialysis graft failure, in the USA alone, are estimated to be in excess of $1 billion.
FloGuardian™ will be the only device on the market that addresses inhibition of both early inhibition of SMCMIH & medium to long term SMCNIH.
Excellent results achieved in pre-clinical studies, with inhibition rates at 30% – 50% inhibition of SMCNIH.